Cargando…
Alterations and Co-Occurrence of C-MYC, N-MYC, and L-MYC Expression are Related to Clinical Outcomes in Various Cancers
BACKGROUND AND OBJECTIVES: MYC, also known as an oncogenic reprogramming factor, is a multifunctional transcription factor that maintains induced pluripotent stem cells (iPSCs). Although MYC is frequently upregulated in various cancers and is correlated with a poor prognosis, MYC is downregulated an...
Autores principales: | Lee, Moonjung, Seok, Jaekwon, Saha, Subbroto Kumar, Cho, Sungha, Jeong, Yeojin, Gil, Minchan, Kim, Aram, Shin, Ha Youn, Bae, Hojae, Do, Jeong Tae, Kim, Young Bong, Cho, Ssang-Goo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Stem Cell Research
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226856/ https://www.ncbi.nlm.nih.gov/pubmed/37105559 http://dx.doi.org/10.15283/ijsc22188 |
Ejemplares similares
-
Systematic expression alteration analysis of master reprogramming factor OCT4 and its three pseudogenes in human cancer and their prognostic outcomes
por: Saha, Subbroto Kumar, et al.
Publicado: (2018) -
Improved Isolation and Culture of Urine-Derived Stem Cells (USCs) and Enhanced Production of Immune Cells from the USC-Derived Induced Pluripotent Stem Cells
por: Kim, Kyeongseok, et al.
Publicado: (2020) -
Multi-Omics Analysis of SOX4, SOX11, and SOX12 Expression and the Associated Pathways in Human Cancers
por: Seok, Jaekwon, et al.
Publicado: (2021) -
Expression of ATP/GTP Binding Protein 1 Has Prognostic Value for the Clinical Outcomes in Non-Small Cell Lung Carcinoma
por: Kwak, Hee Jeong, et al.
Publicado: (2020) -
High Expression of TTYH3 Is Related to Poor Clinical Outcomes in Human Gastric Cancer
por: Saha, Subbroto Kumar, et al.
Publicado: (2019)